Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) issued an announcement. Recently, the company's holding subsidiary Shanghai Zhaohui Pharmaceutical Co., Ltd.'s application for drug registration for dobutamine hydrochloride injection was approved by the State Drug Administration. The approved indications are heart failure due to decreased myocardial contractility during organic heart disease, including low blood loss syndrome after open heart surgery, as a short-term supportive treatment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.